Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shandong Weigao Blood Purification Products Co PEG Ratio?
Shandong Weigao Blood Purification Products CoSHSE:603014 +2.90%36 PEG Ratio is 6.42 as of Jul. 27, 2026, which is 21% below its 10-year median of 8.15. GuruFocus rates SHSE:603014 with a GF Score™ of 36/100. The stock has 3 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Shandong Weigao Blood Purification Products Co ranks worse than 87.44% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
SHSE:603014's PEG Ratio is ranked worse than 87.44% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 1.91
vs SHSE:603014: 6.42
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Shandong Weigao Blood Purification Products Co (SHSE:603014) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Shandong Weigao Blood Purification Products Co PEG Ratio Related Terms
Shandong Weigao Blood Purification Products Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co PEG Ratio Chart
Shandong Weigao Blood Purification Products Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Blood Purification Products Co PEG Ratio vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a PEG Ratio of 6.42 as of Jul. 27, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. This is 21% below median its historical median of 8.15. Over the past decade, Shandong Weigao Blood Purification Products Co's PEG Ratio has ranged from 6.24 to 8.36. According to the industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #181 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 87.4%.
Is Shandong Weigao Blood Purification Products Co's PEG Ratio too high?
Shandong Weigao Blood Purification Products Co's current PEG Ratio of 6.42 is 21% below median its 10-year median of 8.15. Over the past 10 years, this metric has ranged from a low of 6.24 to a high of 8.36. The Medical Devices & Instruments industry median PEG Ratio is 1.91. Shandong Weigao Blood Purification Products Co's value of 6.42 is 236.1% above this industry median. Based on the distribution chart, Shandong Weigao Blood Purification Products Co ranks #181 out of 207 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #181 out of 207 companies for PEG Ratio. This places Shandong Weigao Blood Purification Products Co in the lower half of its industry. The industry median PEG Ratio is 1.91. Shandong Weigao Blood Purification Products Co's value of 6.42 is 236.1% above this benchmark. Historically, Shandong Weigao Blood Purification Products Co's own PEG Ratio has ranged from 6.24 to 8.36 over the past decade. While the company's 10-year median is 8.15 vs. the industry median of 1.91, Shandong Weigao Blood Purification Products Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.91, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Blood Purification Products Co's current PEG Ratio of 6.42 is 236.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Blood Purification Products Co's current PEG Ratio is 6.42, which is 21% below median its own 10-year median of 8.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current PEG Ratio of 6.42. The current PEG Ratio is 6.42, which is 21% below median its 10-year median of 8.15 and 236.1% above the Medical Devices & Instruments industry median of 1.91. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current PEG Ratio is 6.42 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shandong Weigao Blood Purification Products Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603014 has been successfully added to your 
